Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity

Ítems similars

• Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity
  per: Redmond, William L., et al.
  Publicat: (2013)
• Combination OX40 agonism/CTLA-4 blockade with vaccination reverses anergy and primes tumor-specific CD8 T cells in mice with spontaneous prostate cancer
  per: Linch, Stefanie N, et al.
  Publicat: (2013)
• Combined OX40 ligation plus CTLA-4 blockade: More than the sum of its parts
  per: Linch, Stefanie N, et al.
  Publicat: (2014)
• Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T cell anergy and promotes survival in tumor-bearing mice
  per: Linch, Stefanie, et al.
  Publicat: (2015)
• Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice
  per: Linch, Stefanie N., et al.
  Publicat: (2016)